444 filings
Page 6 of 23
8-K
9jc90nd1 kwp51i
14 Feb 22
Departure of Directors or Certain Officers
12:00am
D
7ze4r
24 Jan 22
$5.96M in equity, sold $5.16M, 32 investors
4:21pm
8-K
zhn6wr
12 Jan 22
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics
4:01pm
8-K
enou7
3 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
8-K
j1nfi0j cgy9j
23 Nov 21
AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors
5:24pm
424B5
e9d1a
15 Nov 21
Prospectus supplement for primary offering
7:31am
8-K
wah 8jk0gpp
15 Nov 21
Other Events
6:53am
8-K
v5fb7
15 Nov 21
AcelRx Pharmaceuticals to Acquire Lowell Therapeutics
6:06am
S-8
xjkn8mnpxzpgejsetgo
18 Aug 21
Registration of securities for employees
4:01pm
8-K
61lto 9rnzciyfc2f2h
16 Aug 21
AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:06pm
8-K
g61m2f9
29 Jul 21
Changes in Registrant's Certifying Accountant
4:05pm
8-K
nd9pdxc4 rw
14 Jul 21
AcelRx to receive up to approximately $55 million in combined up-front and sales-based milestone payments for DZUVEO licensing agreement
4:01pm
8-K
f6lid 3xr
17 Jun 21
Departure of Directors or Certain Officers
5:11pm
8-K
ims4t04 3kr
17 May 21
AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
4:10pm
8-K
2kjmd9o6
27 Apr 21
Entry into a Material Definitive Agreement
4:02pm
DEFA14A
9tysw 1pb
23 Apr 21
Additional proxy soliciting materials
9:31am